Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (311-320 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's DiseaseRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic DGK Inhibitors for Treating Metastatic MelanomaRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Piperidinylpyridinylcarbonitrile Derivatives as QPCT and QPCTL Inhibitors for Treating CancerRam W Sabnis
Biophysical Journal|May 7, 2025
Separation of ionic timescales explains dynamics of cellular volume regulationRam M Adar
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Urea-Containing Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy, Hypersomnia, and Sleep Apnea SyndromeRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel HSD17B13 Inhibitors for Treating Liver DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
Pageof 2,416

Showing results (311-320 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's DiseaseRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic DGK Inhibitors for Treating Metastatic MelanomaRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Piperidinylpyridinylcarbonitrile Derivatives as QPCT and QPCTL Inhibitors for Treating CancerRam W Sabnis
Biophysical Journal|May 7, 2025
Separation of ionic timescales explains dynamics of cellular volume regulationRam M Adar
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Urea-Containing Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy, Hypersomnia, and Sleep Apnea SyndromeRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel HSD17B13 Inhibitors for Treating Liver DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
Pageof 2,416